Myoadenylate deaminase deficiency in a child with myalgias induced by physical exercise;Déficit de mioadenilato desaminasa en un niño con mialgias relacionadas con la actividad física

Revista de Neurologia

Volumn 39, Issue 5, 2004, Pages 431-434

  Pantoja Martínez, Jorge ^a   Fernández Balbuena, C Navarro ^b   Gormaz Moreno, M ^a   Quintans Castro, B ^b   Esparza Sanchez M A ^a   Bonet Arzo, J ^a  

^a HOSPITAL DE LA PLANA   (Spain)

^b HOSPITAL DO MEIXOEIRO   (Spain)

Author keywords

Children; Ischemic forearm exercise test; Metabolic disorders; Muscle cramps; Muscle disorders; Muscle pain; Myoadenylate deaminase

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; AMMONIA; CREATINE KINASE; LACTIC ACID;

ADENOSINE MONOPHOSPHATE DEAMINASE DEFICIENCY; ARTICLE; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; ENZYME DEFECT; ENZYME DEFICIENCY; EXERCISE; EXERCISE TOLERANCE; FOREARM; GENETIC ANALYSIS; HOMOZYGOSITY; HUMAN; ISCHEMIA; MALE; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE METABOLISM; MYALGIA; NONSENSE MUTATION; RARE DISEASE; SKELETAL MUSCLE; SYMPTOMATOLOGY;

EID: 8144226808     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3905.2004196     Document Type: Article

References (26)

1. Aicardi J. Diseases of the nervous system in childhood. 2 ed. Oxford: MacKeith Press; 1998.
2. Ashwal S, Peckham N. Myoadenylate deaminase deficiency in children. Pediatr Neurol 1985; 1: 185-91.
3. Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle Nerve 1995; 18: 239-41.
4. Sabina RL, Swan JL, Holmes EW. Myoadenylate deaminase deficiency. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. 7 ed. New York: McGraw-Hill; 1995. p. 1769-80.
5. Morisaki T, Gross M, Morisaki H, Pongratz D, Zollinger N, Holmes EW. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 1992; 89: 6457-61.
6. Dubowitz V. Histological and histochemical stains and reactions. In Dubowitz V, ed. Muscle biopsy. London: Baillieri-Tindall; 1985. p. 19-40.
7. Sabina RL. Myoadenylate deaminase deficiency. In Rosenberg RN, Prusiner SB, DiMauro S, eds. The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann; 1993. p. 261.
8. Coleman RA, Stajich CS, Pact VW, Pericak-Vance MA. The ischemic exercise test in normal adults and in patients with weakness and cramps. Muscle Nerve 1986; 9: 216-21.
9. Sabina RL. Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation. Neurol Clin 2000; 18: 185-94.
10. Lowenstein JM. Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol Rev 1972; 52: 382-14.
11. Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol 1998; 85: 1273-8.
12. Rubio JC, Martín MA, Del Hoyo P, Bautista J, Campos Y, Segura D, et al. Molecular analysis of Spanish patients with AMP deaminase deficiency. Muscle Nerve 2000; 23: 1175-8.
13. Morisaki H, Higuchi I, Abe M, Osame M, Morisaki T. First missense mutations (R288W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient. Hum Mutat 2000; 16: 467-72.
14. Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle Nerve 1995; 18: 239-41.
15. Sabina RL. Myoadenylate deaminase deficiency. Neurol Clin 2000; 18: 185-94.
16. Kar NC, Pearson CM. Muscle adenylic acid deaminase activity: selective decrease in early-onset Duchenne muscular dystrophy. Neurology 1973; 23: 478-82.
17. Fishbein WN. Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 1985; 33: 158-69.
18. Fishbein WN. Primary, secondary, and coincidental types of myoadenilate deaminase deficiency. Ann Neurol 1999; 45: 547-8.
19. Verzijl HT, Van Engelen BG, Luyten JA, Steenbergen GC, Van Den Heuvel LP, Ter Laak HJ, et al. Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol 1998; 44: 140-3.
20. Scola RH, Iwamoto FM, Camargo CH, Arruda WO, Werneck LC. Myotonia congenita and myoadenylate deaminase deficiency: case report. Arq Neuropsiquiatr 2003; 61: 262-4.
21. Rubio JC, Martin MA, Bautista J, Campos Y, Segura D, Arenas J. Association of genetically proven deficiencies of myophosphorylase and AMP deaminase: A second case of double trouble. Neuromuscul Disord 1997; 7: 387-9.
22. Bruno C, Minetti C, Shanske S, Morreale G, Bado M, Cordone G. Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria. Neurology 1998; 50: 296-8.
23. Reuschenbach C, Zierz S. Mutant camitine palmitoyl-transferase associated with myoadenylate deaminase deficiency in skeletal muscle. J Pediatr 1988; 112: 600-3.
24. Zollner N, Reiter S, Gross M, Pongratz D, Reimers CD, Gerbitz K, et al. Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose. Klin Wochenschr 1986; 64: 1281-90.
25. Ren JM, Holloszy JO. Adaptation of rat skeletal muscle to creatine depletion: AMP deaminase and AMP deamination. J Appl Physiol 1992; 73: 2713-6.
26. Baumeister FAM, Gross M, Wagner DR, Pongratz D, Eife R. Myoadenylate deaminase deficiency with severe rhabdomyolisis. Eur J Pediatr 1993; 152: 513-5.